The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...
Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.
The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
Vertex Pharmaceuticals continues to execute its commercialization of three new drugs, JOURNAVX, CASGEVY, and ALYFTREK. Two of which have been approved by the FDA since December. Vertex's valuation ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. For the first time in over two decades, the U.S. Food and Drug Administration (FDA) has ...
More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries. It’s the first new pharmaceutical approach ...
Total sales for the quarter beat analysts’ expectations as revenue from the new treatments soared to bring in more than $5.6 billion combined. With no other major drugs losing patent protection ...
Hosted on MSN15d
FDA approves painkiller designed to eliminate the risk of addiction associated with opioidsWASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin ...
The U.S. Food and Drug Administration has approved Journavx (suzetrigine ... potential as a reliable pain management solution. The new drug is not without potential side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results